Tripeny R Tony

Director Tripeny R Tony bought 4,187 shares of IPX at $23.76; stock down -60.0% from 52-week high amid cluster buy by 3 other insiders in 14 days

Director Tripeny R Tony purchased 4,187 shares at $23.76 on 2026-03-27, establishing an initial position in IPERIONX Ltd (IPX) while the stock trades -60.0% from its 52-week high of $60.11 and -50.5% over the past 30 days. This acquisition occurs in the context of a cluster buy pattern, with 3 other insiders also purchasing shares within the past 14 days, suggesting coordinated or parallel conviction during a period of significant price weakness. Across his cross-ticker track record, the insider has demonstrated a 100% win rate over 90 days with an average 90-day return of +1394.3% on 2 prior open-market buys, though this success reflects activity in other securities and does not guarantee similar performance at this ticker. The concentration of insider purchases during steep price declines warrants close attention to fundamental developments and disclosed reasoning.

Director Tripeny R Tony bought 1,315 shares of MLAB at $76.00 on 2026-03-10; holdings up 32.2%. Stock now -47.0% from 52-week high. Cluster: 2 other insiders also bought within 14 days.

Director Tripeny R Tony purchased 1,315 shares at $76.00, increasing his stake by 32.2% in a single transaction. The purchase follows a meaningful drawdown: the stock trades at $73.23, down 47.0% from its 52-week high of $138.21 and down 21.5% over the past 30 days. Notably, this buy is part of a cluster pattern—2 other insiders also acquired shares within the past 14 days—suggesting coordinated board or management confidence. However, the company's fundamentals present a mixed picture: while revenue grew 11.5% year-over-year to $65.1M in the latest quarter, the company was unprofitable over its most recent full fiscal year and trades at an elevated P/E of 107.69. The insider's cross-ticker track record shows strong historical returns (avg 90d return +1394.3%, 100% win rate across 1 prior buy), though this metric reflects success across multiple stocks, not necessarily predictive power at MLAB specifically.